View Post

Home-based exercise, weight loss interventions do not improve breast cancer-related lymphedema

In Clinical Trials by Barbara Jacoby

By: Schmitz KH, et al. JAMA Oncol. From: healio.com A home-based exercise and/or weight loss intervention failed to improve breast cancer-related lymphedema outcomes among breast cancer survivors with overweight, according to results from the WISER Survivor randomized trial published in JAMA Oncology. “The present study sought to test the effects of exercise, weight loss and combined exercise and weight loss …

View Post

New study examines breast cancer survivors’ experiences managing cancer and work

In In The News by Barbara Jacoby

By: Allison Perry, University of Kentucky From: medicalxpress.com A new study by University of Kentucky researchers examines breast cancer survivors’ experiences with communicating with their oncology team about employment and work issues. Published in the Journal of Cancer Education, the study leaders conducted 24 qualitative interviews with Kentucky breast cancer survivors who were working 30 hours per week or more …

View Post

The power of electromagnetic energy on breast cancer cells

In In The News by Barbara Jacoby

By: Lauren Sharkey From: medicalnewstoday.com Cancer’s ability to spread throughout the body can turn a curable case into an aggressive and sometimes fatal one. A team of engineers and cancer biologists may have found a way to slow down, and even stop, the migration of breast cancer cells.  Cancer, by nature, is a destructive force. Sometimes, it spreads, or metastasizes, …

View Post

Patent reform is needed to protect patients’ access to lifesaving drugs

In In The News by Barbara Jacoby

By: Lyrissa Lidsky From: statnews.com It’s no secret that the cost of prescription drugs is too high for many Americans to afford. Across the country, patients are struggling to access medicines they desperately need. In fact, we are charged, on average, significantly more than residents of other high-income countries for the same prescription drugs. These high prices are due in …

View Post

Review provides new recommendations to manage menopausal symptoms after breast cancer

In In The News by Barbara Jacoby

From: news-medical.net A large proportion of the world’s estimated 9.3 million breast cancer survivors experience menopausal symptoms or clinical manifestations of estrogen deficiency. A comprehensive review published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism focuses on current and future approaches to management of menopausal symptoms after breast cancer. Menopause is a normal part of a woman’s aging …

View Post

Tumor tissue-freezing method may help more women with breast cancer in lower income countries

In In The News by Barbara Jacoby

Source: Johns Hopkins University From: news-medical.net A new reusable device created by the Johns Hopkins University can help women with breast cancer in lower income countries by using carbon dioxide, a widely available and affordable gas, to power a cancer tissue-freezing probe instead of industry-standard argon. A study detailing the tool’s success in animals was published this month in PLOS …

View Post

Dr. Bhave Discusses [Fam-] Trastuzumab Deruxtecan in HER2+ Breast Cancer

In Clinical Trials by Barbara Jacoby

By: Manali Bhave, MD From: onclive.com Manali Bhave, MD, an assistant professor in the Department of Hematology and Medical Oncology at Winship Cancer Institute, Emory University School of Medicine, discusses the promise of [fam-] trastuzumab deruxtecan in HER2-positive breast cancer. [Fam-] trastuzumab deruxtecan is a promising antibody-drug conjugate under investigation. It has a novel payload, which is a topoisomerase inhibitor, …

View Post

Conventional Therapy Outshines Everolimus for Breast Cancer With Certain Mutations

In In The News by Barbara Jacoby

By: Kaitlyn Manasterski From: oncnet.com Everolimus may not be effective for patients with breast cancer and PI3K/AKT/mTOR pathway mutations, according to a recent retrospective cohort study comparing the efficacy of everolimus with conventional therapy in patients with refractory breast cancer and mutations activating the PI3K/AKT/mTOR pathways (Cancer Med. 2019 Aug 6. Epub ahead of print).   “Previous case reports have shown the …

View Post

Experts Argues the Case for Whole Breast Irradiation as Standard of Care for Breast Cancer

In In The News by Barbara Jacoby

By: Nichole Tucker From: targetedonc.com Physicians opinions vary on whether partial breast irradiation (PBI) should be standard of care in breast cancer, according to a vote taken during the 18th Annual International Congress on the Future of Breast Cancer, where physicians did not reach a consensus. Among the physicians that do not believe PBI should be standard of care was …